로딩 중…
지수 로딩 중…
Cell Biotech Co., Ltd.
049960· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩15,470-2.89%
2026-06-19
Price Chart
Cell Biotech Co., Ltd.+17.11%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 145.42B KRW |
| Revenue | 56.49B KRW |
| Net Income | 7.68B KRW |
| Total Assets | 143.29B KRW |
| Net Assets | 133.03B KRW |
| Employees | 123 |
| Value | |
| P/E | 18.95x |
| P/B | 1.09x |
| PEG | 0.12x |
| P/S | 2.57x |
| EV/EBITDA | 24.33x |
| FCF Yield | 5.50% |
| Profitability | |
| ROE | 5.77% |
| ROA | 5.36% |
| Op. Margin | 8.64% |
| Revenue Growth | 30.00% |
| Earnings Growth | 158.57% |
| Financial Health | |
| Debt Ratio | 107.71% |
| Total Debt | 0 KRW |
| FCF | 8.00B KRW |
| Cash | 26.72B KRW |
| Current Ratio | 10.50x |
| Net Debt/EBITDA | -5.48x |
| Dividend | |
| Div. Yield | 3.77% |
| Div. Growth | 33.33% |
| Performance | |
| 1Y Return | 17.11% |
| 1M Return | -12.35% |
| From 52W High | -16.38% |
| 1Y MDD | -19.18% |
| Trading | |
| Volume | 23,544 shares |
| Foreign Own. | 4.33% |
| Per Share | |
| EPS | 1,426 KRW |
| BPS | 19,438 KRW |
Company Info
Cell Biotech was established in 1995 for the research and manufacturing of probiotic lactic acid bacteria products and was listed on KOSDAQ in 2002. The company offers a one-stop solution from probiotic strain development to finished product manufacturing and distribution, achieving the top export position in 2023. By leveraging its dual-coating technology and launching personalized 'Cellbiom' products, Cell Biotech is expanding its business scope and product competitiveness. Cell Biotech is headquartered in Gimpo-si, Gyeonggi-do.